CS logo
small CS logo
Loretto Hospital

Chicago, Illinois, United States
Hospital in Chicago, Illinois
645 S Central Ave, Chicago, IL 60644

About Loretto Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Loretto Hospital


During the past decade, Loretto Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Loretto Hospital" #1 sponsor was "Shire" with 5 trials, followed by "Imara, Inc." with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Kiniksa Pharmaceuticals (UK), Ltd." with 1 trials sponsored and "Zoll Medical Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

Clinical Trials Conditions at Loretto Hospital


According to Clinical.Site data, the most researched conditions in "Loretto Hospital" are "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Heart Failure" (1 trials), "Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention" (1 trials) and "Recurrent Pericarditis" (1 trials). Many other conditions were trialed in "Loretto Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Loretto Hospital


Most popular intervention types in "Loretto Hospital" are "Drug" (6 trials), "Other" (4 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Ontamalimab" (4 trials), "25 mg Ontamalimab" (1 trials), "75 mg Ontamalimab" (1 trials) and "ExPEC9V" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Loretto Hospital


The vast majority of trials in "Loretto Hospital" are 9 trials for "All" genders.

Clinical Trials Status at Loretto Hospital


Currently, there are NaN active trials in "Loretto Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Loretto Hospital, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Loretto Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".